HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic oral administration of 1-nitrosopiperazine at high doses to MRC rats.

Abstract
1-Nitrosopiperazine was fed to two groups of rats as drinking water solutions containing 400 mg/liter (3.5 millimolar) and 800 mg/liter (7.0 millimolar), respectively. The treatment was 20 ml per rat per day, 5 days per week for life. In both groups many animals died with olfactory tumors (mostly esthesioneuroblastomas), the first at 36 weeks in the higher dose group, the first at 64 weeks in the lower dose group. There was also a small number of liver tumors in both groups. None of these tumors was seen in the untreated controls. The similarity of this tumor distribution to that produced by 1,4-dinitrosopiperazine suggests that the observed carcinogenicity of 1-nitrosopiperazine may be entirely due to its disproportionation in the acidic medium of the rat stomach. Chemical data supporting this interpretation are presented.
AuthorsL A Love, W Lijinsky, L K Keefer, H Garcia
JournalZeitschrift fur Krebsforschung und klinische Onkologie. Cancer research and clinical oncology (Z Krebsforsch Klin Onkol Cancer Res Clin Oncol) Vol. 89 Issue 1 Pg. 69-73 (May 20 1977) ISSN: 0084-5353 [Print] Germany
PMID141802 (Publication Type: Journal Article)
Chemical References
  • Carcinogens
  • Nitrosamines
  • Piperazines
Topics
  • Administration, Oral
  • Animals
  • Carcinogens
  • Female
  • Liver Neoplasms (chemically induced)
  • Neoplasms, Experimental (chemically induced)
  • Neuroectodermal Tumors, Primitive, Peripheral (chemically induced)
  • Nitrosamines
  • Olfactory Pathways
  • Piperazines (administration & dosage, toxicity)
  • Rats
  • Rats, Inbred Strains
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: